InTrack Investment Management Inc Cuts Stake in iShares Biotechnology ETF (NASDAQ:IBB)
by Doug Wharley · The Cerbat GemInTrack Investment Management Inc lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 17.7% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 3,011 shares of the financial services provider’s stock after selling 648 shares during the period. InTrack Investment Management Inc’s holdings in iShares Biotechnology ETF were worth $438,000 as of its most recent filing with the SEC.
Other large investors have also added to or reduced their stakes in the company. Global Assets Advisory LLC purchased a new stake in shares of iShares Biotechnology ETF in the first quarter worth about $66,059,000. BNP Paribas Financial Markets boosted its holdings in iShares Biotechnology ETF by 25.7% in the 1st quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock valued at $282,038,000 after purchasing an additional 420,053 shares during the period. Jane Street Group LLC purchased a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at $14,386,000. Cetera Investment Advisers grew its position in shares of iShares Biotechnology ETF by 689.4% during the 1st quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock valued at $12,498,000 after purchasing an additional 79,541 shares in the last quarter. Finally, State of Michigan Retirement System increased its holdings in shares of iShares Biotechnology ETF by 150.0% in the second quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after purchasing an additional 75,000 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.
iShares Biotechnology ETF Stock Performance
iShares Biotechnology ETF stock opened at $145.59 on Friday. The business has a 50-day simple moving average of $145.12 and a 200 day simple moving average of $139.36. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $150.57.
iShares Biotechnology ETF Dividend Announcement
The company also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.
iShares Biotechnology ETF Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Further Reading
- Five stocks we like better than iShares Biotechnology ETF
- What Are the FAANG Stocks and Are They Good Investments?
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- How to Invest in the Best Canadian Stocks
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- MarketBeat Week in Review – 10/7 – 10/11
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).